News

Featured News

  • 2026 |
  • 2025 |
  • 2024 |
  • 2023 |
  • 2022 |
  • 2021 |
  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • Press Release | November 19, 2026

    Ansa Biotechnologies Raises $71.5 Million in Oversubscribed Series C Round to Scale Guaranteed DNA Synthesis

    Read More

    Press Release | November 16, 2026

    GlycoEra Initiates Phase 1a Trial of GE8820, the First IgG4-Selective Degrader to Enter the Clinic

    Read More

    Press Release | November 10, 2026

    Vittoria Biotherapeutics Announces FDA RMAT and Orphan Drug Designations for Senza5 CART5 (VIPER-101) in T-Cell Lymphoma

    Read More

    Press Release | October 22, 2026

    Sundance Biosciences Announces First Patient Dosed in U.S. Phase 2 Clinical Trial of SUN-627 for Progressive Forms of Multiple Sclerosis (MS)

    Read More

    Press Release | October 21, 2026

    Sundance Biosciences Announces Presentation of Phase 1 Results for SUN-627, a Brain-Penetrant TYK2 Inhibitor for the Treatment of Multiple Sclerosis (MS)

    Read More

    Press Release | October 21, 2026

    Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson’s Disease

    Read More

    Press Release | October 13, 2026

    āshibio Presents Preliminary Efficacy Data for Andecaliximab Demonstrating an 86.2% Reduction in New Flare-Up Rate in Patients with FOP

    Read More

    Press Release | October 13, 2026

    āshibio Presents Biomarker Data Supporting Vantictumab Development for ADO2 and a Prevalence Estimate of CLCN7-Related ADO2 of 1–4 per 20,000 Individuals

    Read More

    Press Release | October 9, 2026

    TRexBio Announces Pricing of Initial Public Offering

    Read More

    Press Release | October 5, 2026

    Introducing Fierce Biotech’s 2026 Fierce 15

    Read More

    Press Release | July 27, 2026

    FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

    Read More

    Press Release | July 21, 2026

    Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection

    Read More

    Press Release | July 17, 2026

    Stanford Board of Trustees elects four new members including Agent Capital advisor Farah Champsi

    Read More

    Press Release | July 14, 2026

    Skyhawk Therapeutics Announces Expansion of its Global Pivotal FALCON-HD Clinical Trial for SKY-0515 in Huntington’s Disease to the United States, Canada and the United Kingdom

    Read More

    Press Release | July 9, 2026

    Freenome Reports Top-Line Readout of Updated SimpleScreen™ CRC Colorectal Cancer Screening Blood Test Met All Primary and Secondary Endpoints

    Read More

    Press Release | July 1, 2026

    Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones

    Read More

    Press Release | June 8, 2026

    Incyte to Acquire Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio into Bleeding Disorders

    Read More

    Press Release | May 28, 2026

    Freenome’s SimpleScreen™ CRC Blood-Based Test Included in Updated ACS Colorectal Cancer Screening Guideline

    Read More

    Press Release | May 28, 2026

    Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RD

    Read More

    Press Release | May 19, 2026

    Dragonfly Therapeutics Announces Encouraging Early Results from the Phase 1 for DF5112, its CCR6-Targeting Molecule

    Read More